Concurrent Disorder Management Guidelines. Systematic Review
Open accessThe DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Abstract
Concurrent disorder refers to a diverse set of combinations of substance use disorders and mental disorders simultaneously in need of treatment. Concurrent disorders are underdiagnosed, undertreated, and more complex to manage, practicing the best recommendations can support better outcomes. The purpose of this work is to systematically assess the quality of the current concurrent disorders’ clinical recommendation management guidelines. Literature searches were performed by two independent authors in electronic databases, web, and gray literature. The inclusion criteria were English language clinical management guidelines for adult concurrent disorders between 2000 and 2020. The initial search resulted in 8841 hits. A total of 24 guidelines were identified and assessed with the standardized guidelines assessment tool: AGREE II (Appraisal of Guidelines for Research and Evaluation). Most guidelines had acceptable standards, however, only the NICE guidelines had all detailed information on all AGREE II Domains. Guidelines generally supported combinations of treatments for individual disorders with a very small evidence base for concurrent disorders, and they provided little recommendation for further structuring of the field, such as level of complexity or staging, or evaluating different models of treatment integration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence-based strategies, including contingency management (CM), cognitive-behavioral therapy (CBT), dialectical behavior therapy (DBT), motivational interviewing (MI), acceptance and commitment therapy (ACT), and family-based interventions, have demonstrated their effectiveness in reducing substance use and enhancing treatment outcomes”
From Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review (2024) · cites this paper as [52]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223
Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L. A., & the PRISMA-P Group (2015) · BMJ · doi:10.1136/bmj.g7647 · Cited by 13,120
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Regier, D. A., Farmer, M. E., Rae, D. S., et al. (1990) · PubMed · Cited by 1,913
Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0211 · Cited by 934 · cited 1×
“In population-based studies, approximately one-fourth of people with anxiety or major depressive disorders are expected to have an overlapping substance use disorder in their lifetime [6,7].”
BackgroundGalletly, C., Castle, D., Dark, F., Humberstone, V., Jablensky, A., Killackey, E., Kulkarni, J., McGorry, P., Nielssen, O., & Tran, N. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416641195 · Cited by 877 · cited 1×
“18 Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines for the Management of Schizophrenia and Related Disorders [45] Royal Australian and New Zealand College of Psychiatrists New Zealand and Australia 2016 People with schizophrenia and related disorders”
BackgroundThe AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines
Brouwers, M. C., Kerkvliet, K., Spithoff, K., & AGREE Next Steps Consortium (2016) · BMJ · doi:10.1136/bmj.i1152 · Cited by 785
Implementing Dual Diagnosis Services for Clients With Severe Mental Illness
Drake, R. E., Essock, S. M., Shaner, A., Carey, K. B., Minkoff, K., Kola, L., Lynde, D., Osher, F. C., Clark, R. E., & Rickards, L. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.4.469 · Cited by 693
Mueser, K. T., Drake, R. E., & Wallach, M. A. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00073-2 · Cited by 617
The epidemiology of dual diagnosis
Kessler, R. C. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.034 · Cited by 588 · cited 1×
“In mental health, the focus of research and guidelines has been on individual disorders, despite concurrent disorders being common and seemingly increasing [5].”
BackgroundDua, T., Barbui, C., Clark, N., Fleischmann, A., Poznyak, V., van Ommeren, M., Yasamy, M. T., Ayuso-Mateos, J. L., Birbeck, G. L., Drummond, C., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001122 · Cited by 384
Integrated treatment of substance use and psychiatric disorders
Kelly, T. M., & Daley, D. C. (2013) · Social Work in Public Health · doi:10.1080/19371918.2013.774673 · Cited by 378
Integrating the Hierarchical Taxonomy of Psychopathology (HiTOP) into clinical practice.
Ruggero, C. J., Kotov, R., Hopwood, C. J., First, M., Clark, L. A., Skodol, A. E., Mullins-Sweatt, S. N., Patrick, C. J., Bach, B., Cicero, D. C., et al. (2019) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000452 · Cited by 333 · cited 1×
“, the HiTOP model [88], played no role in the current conceptualization of concurrent disorders and played no role in the development of the guidelines.”
MethodLingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332 · cited 3×
““BAP Updated Guidelines: Evidence-Based Guidelines for the Pharmacological Management of Substance Abuse, Harmful Use, Addiction and Comorbidity: Recommendations from BAP” were extremely clear on the scope and were developed with the utmost rigor and scored close to the possible maximum, with only minimal missing info…”
BackgroundBarriers to the Care of Persons With Dual Diagnoses: Organizational and Financing Issues
Ridgely, M. S., Goldman, H. H., & Willenbring, M. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.1.123 · Cited by 320
The Mental Health Policy Implementation Guide
(2013) · PsycEXTRA Dataset · doi:10.1037/e623632007-001 · Cited by 274
Ramasubbu, R., Taylor, V. H., Samaan, Z., Sockalingham, S., Li, M., Patten, S., Rodin, G., Schaffer, A., Beaulieu, S., & McIntyre, R. S. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400110 · Cited by 206
ZIEDONIS, D. M., SMELSON, D., ROSENTHAL, R. N., BATKI, S. L., GREEN, A. I., HENRY, R. J., MONTOYA, I., PARKS, J., & WEISS, R. D. (2005) · Journal of Psychiatric Practice · doi:10.1097/00131746-200509000-00005 · Cited by 195
Co-occurring disorders in substance abuse treatment: Issues and prospects
Flynn, P. M., & Brown, B. S. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2006.11.013 · Cited by 178
Co-Occurring Psychotic and Addictive Disorders: Neurobiology and Diagnosis
Ross, S., & Peselow, E. (2012) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e318261e193 · Cited by 170
Minkoff, K. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.5.597 · Cited by 158
Rüther, T., Bobes, J., De Hert, M., Svensson, T. H., Mann, K., Batra, A., Gorwood, P., & Möller, H. J. (2014) · European Psychiatry · doi:10.1016/j.eurpsy.2013.11.002 · Cited by 149 · cited 3×
“2020, 9, 2406; doi:10.3390/jcm9082406 www.mdpi.com/journal/jcm Mental Illness” (CAMI), “Mental Illness Chemically Affected” (MICA), “Substance Affected Mentally Ill” (SAMI), “Mental Illness Substance Affected” (MISA), “Mental Illness Substance Use Disorder” (MISUD), and “Individuals with Co-Occurring Psychiatric and S…”
BackgroundInfluentialHasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthøj, B., Gattaz, W. F., Thibaut, F., Möller, H.-J., & on behalf of the WFSBP Task Force on Treatment Guidelines for Schizophrenia (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1009163 · Cited by 145
Aharonovich, E., Liu, X., Nunes, E., & Hasin, D. S. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.9.1600 · Cited by 141
Drake, R. E., Mueser, K. T., & Brunette, M. F. (2007) · PubMed · Cited by 139
Crockford, D., & Addington, D. (2017) · The Canadian Journal of Psychiatry · doi:10.1177/0706743717720196 · Cited by 113
Substance Abuse With Mental Disorders: Specialized Public Systems And Integrated Care
Burnam, M. A., & Watkins, K. E. (2006) · Health Affairs · doi:10.1377/hlthaff.25.3.648 · Cited by 108
Pennay, A. E., Cameron, J., Reichert, T., Strickland, H., Lee, N., Hall, K., & Lubman, D. I. (2011) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2011.05.004 · Cited by 106
Psychiatric disease and drug abuse
Santucci, K. (2012) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283504fbf · Cited by 97 · cited 1×
“Additionally, the impact of substance use disorders and non-substance-use mental disorders interact, affecting the course and prognosis of both [15,17].”
BackgroundDrake, R. E., Wallach, M. A., & McGovern, M. P. (2005) · Psychiatric Services · doi:10.1176/appi.ps.56.10.1297 · Cited by 92
Watkins, K. E., Hunter, S. B., Burnam, M. A., Pincus, H. A., & Nicholson, G. (2005) · Psychiatric Services · doi:10.1176/appi.ps.56.8.913 · Cited by 87
Fridell, M., Bäckström, M., Hesse, M., Krantz, P., Perrin, S. G., & Nyhlén, A. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2098-3 · Cited by 81
Clinical Treatment Matching Models for Dually Diagnosed Patients
Ries, R. K. (1993) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30199-0 · Cited by 77
A Review of Integrated Care for Concurrent Disorders: Cost Effectiveness and Clinical Outcomes
Karapareddy, V. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2018.1518553 · Cited by 77
Canaway, R., & Merkes, M. (2010) · Australian Health Review · doi:10.1071/ah08723 · Cited by 71
Clinical Handbook of Co-existing Mental Health and Drug and Alcohol Problems
(2007) · Routledge eBooks · doi:10.4324/9780203028513 · Cited by 67
Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE)
Back, S. E., Foa, E. B., Killeen, T. K., Mills, K. L., Teesson, M., Cotton, B. D., Carroll, K. M., & Brady, K. T. (2015) · Oxford University Press eBooks · doi:10.1093/med:psych/9780199334537.001.0001 · Cited by 65
Zhang, L., Norena, M., Gadermann, A., Hubley, A., Russell, L. B., Aubry, T., To, M. J., Farrell, S., Hwang, S. W., & Palepu, A. (2018) · Journal of dual diagnosis · doi:10.1080/15504263.2017.1392055 · Cited by 61
Psychiatric comorbidity in alcohol use disorders: results from the German S3 guidelines
Preuss, U. W., Gouzoulis‐Mayfrank, E., Havemann‐Reinecke, U., Schäfer, I., Beutel, M. E., Hoch, E., & Mann, K. F. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0801-2 · Cited by 52
Concurrent mental and substance use disorders in Canada.
Khan, S. (2017) · PubMed · Cited by 51
Defining dual diagnosis of mental illness and substance misuse: some methodological issues
TODD, J., GREEN, G., HARRISON, M., IKUESAN, B. A., SELF, C., BALDACCHINO, A., & SHERWOOD, S. (2004) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/j.1365-2850.2004.00683.x · Cited by 49
Baandrup, L., Rasmussen, J. Ø., Klokker, L., Austin, S. F., Bjørnshave, T., Bliksted, V., Fink‐Jensen, A., Fohlmann, A., Hansen, J. P., Nielsen, M. K., et al. (2015) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2015.1074285 · Cited by 43
Drug misuse and suicide: a tale of two services
Appleby, L. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.9521752.x · Cited by 39
Beaulieu, S., Saury, S., Sareen, J., Tremblay, J., Schütz, C. G., McIntyre, R. S., & Schaffer, A. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400105 · Cited by 38 · cited 1×
“7 The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Management of Patients with Mood Disorders and Comorbid Substance Use Disorders [34] CANMAT Canada 2012 People with mood disorders and comorbid substance use disorders”
BackgroundDeveloping Welcoming Systems for Individuals with Co-Occurring Disorders
Minkoff, K., & Cline, C. A. (2005) · Journal of Dual Diagnosis · doi:10.1300/j374v01n01_06 · Cited by 33
Perron, B. E., Bunger, A. C., Bender, K., Vaughn, M. G., & Howard, M. O. (2010) · Substance Use & Misuse · doi:10.3109/10826080903442836 · Cited by 30
Minkoff, K. (2000) · Disease Management & Health Outcomes · doi:10.2165/00115677-200008050-00001 · Cited by 29
Models of Concurrent Disorder Service: Policy, Coordination, and Access to Care
Wiktorowicz, M. E., Abdulle, A., Pierdomenico, K. D., & Boamah, S. A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00061 · Cited by 28
Brousselle, A., Lamothe, L., Mercier, C., & Perreault, M. (2007) · Evaluation and Program Planning · doi:10.1016/j.evalprogplan.2006.10.005 · Cited by 26
Barreira, P. J., Espey, B., Fishbein, R., Moran, D., & Flannery, R. B. (2000) · The Journal of Behavioral Health Services & Research · doi:10.1007/bf02287808 · Cited by 26
Dual Diagnosis: Focusing on Depression and Recommendations for Treatment
Torrens, M., Martínez-Sanvisens, D., Martinez-Riera, R., Bulbena, A., Szerman, N., & Ruiz, P. (2011) · Addictive Disorders & Their Treatment · doi:10.1097/adt.0b013e318215f322 · Cited by 23
The British experience of dual diagnosis in the national health service
Lowe, A., & Abou‐Saleh, M. T. (2004) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2004.0060.x · Cited by 22
Dual Diagnosis Capability: Moving from Concept to Implementation
Minkoff, K., & Cline, C. A. (2006) · Journal of Dual Diagnosis · doi:10.1300/j374v02n02_09 · Cited by 21
Validation of the Co-occurring Disorder Quadrant Model
McDonell, M. G., Kerbrat, A. H., Comtois, K. A., Russo, J. E., Lowe, J. M., & Ries, R. K. (2012) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2012.705065 · Cited by 12
Guideline for Screening, Diagnosis and Treatment of ADHD in Adults with Substance Use Disorders
Matthys, F., Stes, S., van den Brink, W., Joostens, P., Möbius, D., Tremmery, S., & Sabbe, B. (2014) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-014-9496-z · Cited by 12
Bernardy, N. C., Hamblen, J. L., Friedman, M. J., & Kivlahan, D. R. (2011) · Journal of Dual Diagnosis · doi:10.1080/15504263.2011.620446 · Cited by 10
Keyser, D. J., Watkins, K. E., Vilamovska, A., & Pincus, H. A. (2008) · Psychiatric Services · doi:10.1176/ps.2008.59.11.1251 · Cited by 9
Zaleski, M., Laranjeira, R., Marques, A. C. P. R., Ratto, L. R. C., Romano, M., Alves, H. N. P., Soares, M. B. D. M., Abelardino, V., Kessler, F. H. P., Brasiliano, S., et al. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1285552 · Cited by 9
Integrated Treatment for Mood and Substance Use Disorders
Westermeyer, J. J. (2004) · Johns Hopkins University Press eBooks · doi:10.1353/book.20641 · Cited by 8
Treatment of PTSD and Comorbid Disorders
Cobham, V. E., & Hiller, R. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108235655.033 · Cited by 7
Best Practices for Co-Occurring Disorders
Ronis, R. J. (2005) · Journal of Dual Diagnosis · doi:10.1300/j374v01n03_10 · Cited by 3
PUBLIC POLICY STATEMENT ON CO-OCCURRING ADDICTIVE AND PSYCHIATRIC DISORDERS
(2001) · Journal of Addictive Diseases · doi:10.1300/j069v20n03_10 · Cited by 3
Integrated Treatment for Co-Occurring Disorders
Textbook, M. (2017) · Cited by 2
Research works printed but not linked: 5
- Torres, 2019, Dual Diagnosis: A Theoretical Approximation from Review of Literature, J. Drug Abus., 5, 4
- Dennis, C.D., and Douathy, A. (2006). Addiction and Mood Disorders-A Guide for Clients and Families, Oxford University Press.
- Bellack, S.A., Bennett, E., and Gearon, S.J. (2007). Behavioral Treatment for Substance Abuse in People with Serious and Persistent Mental Illness: A Handbook for Mental Health Professionals, Routledge.
- Gray, 2009, Tobacco smoking in individuals with attention-deficit hyperactivity disorder, CNS Drugs, 23, 661
- Noordsy, D.L., Fox, L., Drake, E.R., Mueser, T.K., and Smith, F.L. (2003). Integrated Treatment for Dual Diagnosis Disorders: A Guide to Effective Practice, The Guilford Press.
Cited by
Bahji, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13040999 · Cited by 83
Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice
Martinotti, G., Chiappini, S., Mosca, A., Miuli, A., Santovito, M. C., Pettorruso, M., Skryabin, V. Y., Sensi, S. L., & Giannantonio, M. D. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220623092853 · Cited by 60
Glover‐Wright, C., Coupe, K., Campbell, A. C., Keen, C., Lawrence, P., Kinner, S. A., & Young, J. T. (2023) · Drug and Alcohol Review · doi:10.1111/dar.13651 · Cited by 46
Special Issue: Diagnosis and Management of Addiction and Other Mental Disorders (Dual Disorders)
Adán, A., & Torrens, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061307 · Cited by 37
Miguel, N., Marquez-Arrico, J. E., Jódar, M., Navarro, J. F., & Adán, A. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.06.006 · Cited by 35
Metadata
- Authors
- Hakobyan, S., Vazirian, S., Lee-Cheong, S., Krausz, M., Honer, W. G., & Schutz, C. G.
- Affiliations
- University of British Columbia (CA)
- King's College London (GB)
- Department of Psychiatry, The University of British Columbia, Vancouver, BC V6T 1Z4, Canada
- Corresponding author
- Hakobyan, Syune
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2020-07-28
- Volume
- 9
- Issue
- 8
- Pages
- 2406
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC7463987
- OpenAlex
- W3046093029
- Cited by
- 99
- References
- 66
- Citations by year
- 2026: 18 · 2025: 25 · 2024: 17 · 2023: 15 · 2022: 12 · 2021: 12
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- cIRcle (University of British Columbia) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of British Columbia
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- concurrent disorders, dual diagnosis, substance use disorders, mental illness, guideline quality assessment, AGREE II, NICE guidelines, integrated treatment model, treatment complexity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
